Table 2 Number of anti-hypertensive drug classes among patients with uncontrolled BP (≥140/90 mmHg) according to age groups, health conditions and laboratory markers
Variables | N | Number of anti-hypertensive drug classes | P-value | ||||
|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 + | |||
Age group (years) | |||||||
  ≥ 18 to < 45 | 39 | 5 (12.8) | 14 (35.9) | 11 (28.2) | 4 (10.3) | 5 (12.8) | 0.001 |
  ≥ 45 to 65 | 141 | 11 (7.8) | 38 (27.0) | 28 (19.9) | 40 (28.4) | 24 (17.0) |  |
  ≥ 65 | 490 | 24 (4.9) | 77(15.7) | 153 (31.2) | 142 (29.0) | 94 (19.2) |  |
Diabetes | |||||||
 Yes | 348 | 8 (2.3) | 57 (16.4) | 97 (27.9) | 108 (31.0) | 78 (22.4) | 0.001 |
 No | 322 | 32 (9.9) | 72 (22.4) | 95 (29.5) | 78 (24.2) | 45 (14.0) |  |
Obesity | |||||||
 Yes | 331 | 10 (3.0) | 63 (19.3) | 93 (28.1) | 97 (29.3) | 68 (20.5) | 0.014 |
 No | 326 | 30 (9.2) | 63 (19.3) | 95 (29.1) | 84 (25.8) | 54 (16.6) |  |
CVD | |||||||
 Yes | 337 | 14 (4.2) | 45 (13.4) | 98 (29.1) | 105 (31.2) | 75 (22.3) | 0.001 |
 No | 333 | 26 (7.8) | 84 (25.2) | 94 (28.2) | 81 (24.3) | 48 (14.4) |  |
eGFR | |||||||
  ≥ 45 to < 60 | 121 | 10 (8.3) | 32 (26.5) | 37 (30.6) | 24 (19.8) | 18 (14.9) | 0.138 |
  ≥ 30 to < 45 | 272 | 16 (5.9) | 50 (18.4) | 85 (31.3) | 75 (27.6) | 46 (16.9) |  |
  ≥ 15 to < 30 | 277 | 11 (5.1) | 33 (15.1) | 59 (27.1) | 70 (32.1) | 45 (20.6) |  |
  < 15 |  | 3 (5.1) | 14 (23.7) | 11 (18.6) | 17 (28.8) | 14 (23.7) |  |
ACR/PCR categories | |||||||
 Normal | 141 | 7 (5.0) | 34 (24.1) | 47 (33.3) | 37 (26.2) | 16 (11.4) | 0.042 |
 Mild | 202 | 18 (8.9) | 36 (17.8) | 61 (30.2) | 53 (26.2) | 34 (16.8) |  |
 Severe | 313 | 13 (4.2) | 57 (18.2) | 84 (26.8) | 88 (28.1) | 71 (22.7) |  |